After 1.5 years of clinical pathology residency at the University of Pennsylvania, he moved to Baylor College of Medicine in 1991 to continue his residency and initiate postdoctoral research. In 1993, he started his independent research laboratory in the Department of Pathology.
unraveled the developmental and postnatal roles of activin signaling pathway components (ligands, receptors, and transducers), identified GDF9/BMP15 as an oocyte-secreted growth factor, uncovered dozens of testis-specific genes and defined their physiological roles, and demonstrated the oviduct origin of ovarian cancer.
Professor Matzuk was one of the first investigators in the field of reproduction research to generate knockout mouse models "in-house," making more than 100 strains to date for use by other scientists all over the world. He is well known for his tireless dedication and unmatched work ethic at the bench and his ceaseless intellectual drive. He has been highly prolific. He published more than 300 peer-reviewed publications and holds 13 patents. Publications from his laboratory have been highly cited and they reflect the highest quality-the key aspects that he instills in and brings out from all his trainees. He has written several authoritative reviews in high impact journals. He served several scientific societies in various capacities, and served as a member on multiple NIH study sections and as a Chair of the REB/CMIR NIH study section. My father, Alexander R. Matzuk, a World War II veteran, spent 25 years at Merck in Rahway, NJ. He was an inventor on 20 patents and he helped develop many blockbuster drugs at Merck including Mintezol (thiabendazole), Indocin (indomethacin), Flexeril (cyclobenzaprine), and Dolobid (diflunisal), which remain on the market today. My father and mother, Gloria Buhl Matzuk (who met my father at Merck), were both inspirations but they never pushed me into medicine and research-it was something that I liked from an early age and wanted to do. To honor my father, we have an annual symposium in our center entitled the "Alexander R. Matzuk Lecture in Drug Discovery."
You took pretty much a "reductionist" approach while you were a graduate student and used site directed mutagenesis to define the biological roles of glycan chains on glycoprotein hormones. How did you decide to switch to working with mouse models and effectively using several in vivo approaches since then?
The papers by Drs. Ralph Brinster and Richard Palmiter in the early 1980s and studies by Dr Allan Bradley and others later in the decade got me excited about working with transgenic mice and moving from cell culture to animal models in my research progression. When I was deciding on postdoctoral experiences, I interviewed at Baylor College of Medicine with Allan and was lucky enough to receive an NIH K11 Physician Scientist Award from NICHD, which allowed me invaluable protected time from my clinical duties to be able to generate knockouts of the inhibin and activin subunits to study their in vivo functions.
You have consistently published your research work in very high impact journals. What do you think is the most significant contribution you have made?
As you know, we have produced over 100 transgenic mouse models, and I feel that we have learned much from every knockout mouse that we have created. Of course, the growth differentiation factor 9 and follicle stimulating hormone β knockout models that we both have co-authored are my most highly cited papers to date and along with the inhibin/activin subunit knockouts helped to jump start my academic career. Our studies with the BRDT inhibitor, JQ1, helped me to redirect a portion of my research program toward male contraception and was my impetus to creating and becoming the inaugural director of the Center for Drug Discovery at Baylor College of Medicine.
During your long career, you have very effectively used both in vitro and in vivo approaches. How have you been so successful with this combinatorial approach?
Throughout my career, I have been a big fan of cutting-edge technologies. In vitro approaches typically get you an answer faster, but in vivo technologies allow you to define essential functions of a protein. Both approaches go hand in hand.
To date you have "dived" into research on all major reproductive organs and made phenomenal contributions in each of these areas. Are you still pursuing any particular topic that you think has remained unsolved for a long time in your laboratory?
There are still lots of genes for which their function in vivo remains unknown. Thus, we are continuing to make knockouts and knockins to study novel pathways in the reproductive axis. Also, with our recent NIH P01 program project from NICHD and grant from the Bill and Melinda Gates Foundation, we have been able to devote a lot more effort to creating novel male contraceptives, something I feel is desperately needed for society and for which I am very passionate.
Your dedication and tireless hard work to science are very inspiring to many. Are there individuals who influenced you at any stage of your career and how did it impact you?
My father and mother were influential early in life, Nicholas Cozzarelli gave me my first chance in science as an undergraduate, Irving Boime was a great PhD advisor, and he and his wife Melody continue to be my friends. Allan Bradley initiated my "in vivo career," and most recently, Masahito Ikawa and his group enabled us to study gene function in mice using CRISPR/Cas9 at a far more rapid pace than the traditional knock-out approaches I originally used. Many additional colleagues, staff, trainees, friends, and family have also had major influences on who I am today.
How did you balance each of the major academic activities-mentoring, research and administrative responsibilities all along your career?
Balance is not easy and sometimes one area does not get my effort it deserves. You must constantly choose wisely to avoid tipping the balance. In particular, you need to stay focused and not get too distracted and choose an area of passion-reproductive medicine has been that area for me. And never forget how important life balance is. I swim every day and get away to SCUBA dive as often as possible.
Starting as a resident and postdoctoral fellow and until now you remained at Baylor College of Medicine. What is the secret behind this dedication to a single Institution?
Baylor College of Medicine and Houston have been very special places for me. I met my wife here! Despite multiple offers from other institutions, I've stayed loyal to Baylor College of Medicine because of the great community here-colleagues, trainees, and staff, and support that has allowed me to flourish. Houston has great people, great outdoor experiences, which include alligators, beaches, and birds, great restaurants, great sports, and easy access to great dive destinations. It was a wonderful place to raise a family.
What is your perspective about where reproductive medicine research is heading? And what advice would you give to current trainees in reproductive biology?
There are so many aspects of reproductive medicine, so many niches and very broad topics, and so much that we still do not understand. Reproduction at the basic and clinical levels remains exciting. For trainees, spend as much time at the bench and not on your computer or cell phone; you can only get lucky if you do an experiment.
Also, this hands-on research will help you become a better experimentalist and will help you to publish more papers as a trainee. These papers are critical for grant funding at every level of your career.
I remember besides Science, you are also very passionate about swimming and scuba-diving with your family and following professional sports like baseball and basketball. Do you still pursue these hobbies and enjoy them as you used to?
As mentioned above, Houston has been a great place to live and raise a family. I work to have work-life balance. Swimming remains my daily passion; I can swim every day of the year outdoors in this warm climate. My wife, Lynn, and our now-grown sons, A.J., Bryan, and Ryan are great SCUBA diving buddies! Since the early 1990s when you were here, I have been a Houston Rockets fan and Lynn and I have season tickets-we feel that this is their year! What can I say about the Houston Astros? We were lucky enough to have tickets to last year's World Series games 3 and 5. We are excited for the season to start again!
